|
COPYRIGHT 2008 SourceMedia, Inc.
Byline: Richard Kellerhahs
Credit Suisse and Wachovia are hoping to inject some life into the leveraged loan market with a new $1 billion term loan B for King Pharmaceuticals, a Bristol, Tenn.-based drug company. Price talk has yet to be determined.
The proceeds from the facility, which will come in two $500 million chunks, will help fund the acquisition ofBridgewater, N.J.-based pharmaceutical company Alpharma. It could not be determined when...
Read the full article for free courtesy of your local library.
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
